NASDAQ:AMAG
Delisted

Amag Pharmaceuticals Stock Forecast

etoro logo Buy AMAG
*Your capital is at risk
$13.75
+0 (+0%)
At Close: May 27, 2022

AMAG Performance

FAQ

What is the symbol for AMAG Pharmaceuticals Stock and on which exchange is it traded?
The symbol for AMAG Pharmaceuticals is AMAG and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell AMAG Pharmaceuticals Stock?
AMAG Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy AMAG Pharmaceuticals Stock?
AMAG Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AMAG Pharmaceuticals Stock.

What's the current price of AMAG Pharmaceuticals Stock?
As of the end of day on the May 27, 2022, the price of an AMAG Pharmaceuticals (AMAG) share was $13.75.

What is the 52-week high and low for AMAG Pharmaceuticals Stock?
The 52-week high for AMAG Pharmaceuticals Stock is $13.75 and the 52-week low is $13.75.
Click to get the best stock tips daily for free!
ABOUT AMAG PHARMACEUTICALS
AMAG Pharmaceuticals
AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company, provides products and services with a focus on maternal health, anemia management, and cancer supportive care in the United States. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Feraheme (ferumoxytol) injection for use as an intravenous (IV...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
4.95% Jun 05
TPR
$140.47
0.320% Jun 04
N
NVRI
$19.53
4.92% May 20
GLBE
$31.61
3.54% May 05
FIZZ
$34.11
8.80% May 01

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE